Dana E. Selley - Concepedia

Author

Dana E. Selley

Virginia Commonwealth University ORCID

Also Known As

D E Selley, D. E. Selley, D.E. Selley, Dana E Selley, Dana E. Selley, Dana Selley, Dana E. Selley

406

Publications

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Wake Forest University Virginia Commonwealth University Medical Center Scripps Research Institute Atrium Health Wake Forest Baptist

About

Dana E. Selley is an author at Virginia Commonwealth University specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	53	5.1K
2	Social Sciences	21	26	2.3K
3	Health Sciences	10	10	1.4K
4	Natural Sciences	2	2	45
5	Engineering	1	1	13

Dana E. Selley

106

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Jonathan Z. Long, Weiwei Li, Lamont Booker, Nature Chemical Biology Cannabis UseMolecular PharmacologySelective BlockadeHealth SciencesFunctional Selectivity	2008	925
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Joel E. Schlosburg, Jacqueline L. Blankman, Jonathan Z. Long, Nature Neuroscience Cannabis UseEndocannabinoid SystemBiochemistryMedicineNeuropharmacology	2010	624
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Laura J. Sim, Dana E. Selley, Steven R. Childers Proceedings of the National Academy of Sciences Excess GdpSocial SciencesRat BrainMolecular PharmacologyReceptor-activated G Proteins	1995	455
An essential role for ΔFosB in the nucleus accumbens in morphine action Venetia Zachariou, Carlos A. Bolaños, Dana E. Selley, Nature Neuroscience Molecular PharmacologyEssential RoleBehavioral NeuroscienceNeuroanatomySynaptic Transmission	2006	268
RGS9 Modulates Dopamine Signaling in the Basal Ganglia Zia Ur Rahman, Johannes Schwarz, Stephen J. Gold, Neuron MedicinePhysiologyNeurotransmitterNeuropharmacologyNeuroscience	2003	264
Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists John W. Huffman, Gülay Zengin, Ming‐Jung Wu, Bioorganic & Medicinal Chemistry Cannabis UseMolecular PharmacologyCb2 ReceptorsBiochemistryMedicine	2004	256
Essential role for RGS9 in opiate action Venetia Zachariou, Dan Georgescu, Nick Sanchez, Proceedings of the National Academy of Sciences	2003	248
Distinct patterns of ΔFosB induction in brain by drugs of abuse Linda I. Perrotti, R.R. Weaver, Barrie D. Robison, Synapse NeuropsychologyPsychopharmacologyDeltafosb InductionRodent BrainSocial Sciences	2008	214
Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPγS Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP Affinity C. S. Breivogel, Dana E. Selley, Steven R. Childers Journal of Biological Chemistry	1998	187
Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects Steven G. Kinsey, Laura E. Wise, Divya Ramesh, Journal of Pharmacology and Experimental Therapeutics	2013	167

Page 1